Experts discuss future of implantology in Gothenburg

GOTHENBURG, Sweden/LEIPZIG, Germany: Professor Per-Ingvar Brånemark from Sweden has urged dentist worldwide to refocus on their patients needs. Despite all recent developments in oral and maxillofacial reconstruction, the field should put more efforts to the development of simple and affordable solutions rather than following commercial interests, he told Dental Tribune Online during an exclusive interview at the first P-I Brånemark Symbosium in Gothenborg last week.

80-year old Brånemark was the first clinician to place a modern dental implant back in 1965. He also discovered the concept of osseointegration which had a huge impact on oral rehabilitation and other clinical disciplines such as orthopaedics.

The P-I Brånemark Symposium, which is supported by dental heavyweight Nobel Biocare, is supposed to be the first in a number of interdisciplinary events that focuses on issues like the quality of life, economic and ethics in regard to oral rehabilitation. It drew over 250 international scientist and dental experts to Gothenburg in order to met and discuss the latest concepts and developments in oral and maxillo-facial reconstruction including latest advancements in implant surfaces, bone augmentation, as well as imaging and CAD/CAM-based prosthetics.

The meeting also presented new studies revealing promising satisfaction figures among patients that received treatment with dental implants.

”Osseointegration has been the major breakthrough in 20th century oral rehabilitation and brought together clinicians from different disciplines who otherwise may not have met.” said Dr Daniel van Steenberghe, Belgium, Scientific Chairman of the Symposium.” The purpose of this meeting is to enhance this cooperation for the sake of the patient.”

According to latest industry figures, the worldwide market volume for dental implants was US$700 million in 2008 making it the fastest growing business sector in dentistry. According to industry experts, this volume is expected to increase further due to lower delivery costs and better long-term clinical results.